Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001641172-25-021499
Filing Date
2025-07-30
Accepted
2025-07-30 08:40:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5645
  Complete submission text file 0001641172-25-021499.txt   7308
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Subject) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-84151 | Film No.: 251164109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CERECOR INC. 400 E. PRATT STREET, SUITE 606 BALTIMORE MD 21202
Business Address
Crutcher Patrick J (Filed by) CIK: 0001754540 (see all company filings)

Type: SCHEDULE 13G/A